In addition, FOXA1 and GATA3 are frequently targeted by mutations in breast cancer [43] (Fig. S11), while PBX1 is rarely affected by somatic mutations (V117M and H425N, 2 out of 892 patients). Here, GATA3 is linked to breast carcinoma.